Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9216169
APP PUB NO 20150011598A1
SERIAL NO

14367961

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a pharmaceutical composition comprising candesartan or ester thereof and chlorthalidone, and use thereof, wherein the weight ratio of candesartan or ester thereof to chlorthalidone is 5.3:1 to 1:6.25. The pharmaceutical composition has a synergistic antihypertensive effect, and can enhance the antihypertensive effect and extend duration of antihypertension.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH300193 TIANJIN CITY NANKAI DISTRICT ANSHAN WEST ROAD NO 308 TIANJINCITY TIANJINCITY 300193

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hao, Chunhua Tianjin, CN 1 0
Tang, Lida Tianjin, CN 15 45
Wang, Weiting Tianjin, CN 7 12
Xi, Wengong Tianjin, CN 1 0
Xu, Xiangwei Tianjin, CN 1 0
Yu, Bing Tianjin, CN 323 612
Zhao, Zhuanyou Tianjin, CN 2 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00